Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-26

Clinical Trial Update: Insulin Glargine "All to Target" Trial [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports completed results for insulin glargine in type 2 diabetes, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2011-04-26